4//SEC Filing
Ludwig Jeffrey Jerome 4
Accession 0001209191-21-012573
CIK 0001401667other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 7:25 PM ET
Size
8.0 KB
Accession
0001209191-21-012573
Insider Transaction Report
Form 4
Ludwig Jeffrey Jerome
Chief Commercial Officer
Transactions
- Award
COMMON STOCK
2021-02-17+36,069→ 36,069 total - Award
STOCK OPTION (RIGHT TO BUY)
2021-02-17+50,740→ 50,740 totalExercise: $12.02Exp: 2031-02-26→ COMMON STOCK (50,740 underlying)
Footnotes (2)
- [F1]Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to (i) one-third (1/3) of the Restricted Stock Units on the vesting commencement date of January 1, 2021 (the "Vesting Commencement Date") and (ii) one-sixth (1/6th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024.
- [F2]Subject to the Optionee's continued service with the Company through the applicable vesting date, the Option shall vest and become exercisable with respect to (i) one-third (1/3) of the Shares (as defined in the Plan) underlying the Option on the vesting commencement date of January 1, 2021 (the "Vesting Commencement Date") and (ii) one-sixth (1/6th) of the Shares subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023, and January 1, 2024.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001807133
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 7:25 PM ET
- Size
- 8.0 KB